Tissue Regenix Group plc

AIM:TRX Stock Report

Market Cap: UK£5.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Tissue Regenix Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TRX?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme161,0680.226%
Public Companies216,8890.304%
General Public4,312,2166.05%
Individual Insiders4,859,6296.82%
Private Companies8,485,45011.9%
Institutions53,199,25574.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 91.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.1%
Harwood Capital LLP
15,730,000UK£1.1m-0.38%0.12%
13.2%
Hargreaves Lansdown Asset Management Ltd.
9,424,900UK£683.3k130%no data
9.1%
Lombard Odier Asset Management (Europe) Ltd.
6,485,492UK£470.2k-27.6%0.01%
8.55%
Aberdeen Group Plc
6,087,670UK£441.4k46.7%no data
6.41%
Richard Griffiths
4,569,690UK£331.3k-0.03%no data
5.81%
Lexham Special Opportunities I LP
4,140,025UK£300.2k0%no data
4.81%
HBOS Investment Fund Managers Limited
3,425,643UK£248.4k82.6%no data
4.49%
Ora Global Limited
3,197,500UK£231.8k0%no data
3.36%
IP Group Plc
2,390,403UK£173.3k0%0.11%
3.11%
Barclays Bank PLC
2,212,104UK£160.4k15.5%no data
1.55%
Stockinvest Limited
1,105,000UK£80.1k0%no data
1.07%
Lombard Odier Asset Management (USA) Corp
761,632UK£55.2k-16.8%0.01%
1%
Stifel Asset Management Corp.
712,832UK£51.7k157%no data
0.73%
TrinityBridge Limited
518,120UK£37.6k41.1%no data
0.67%
HSBC Global Asset Management (UK) Limited
479,704UK£34.8k52%no data
0.67%
Brewin Dolphin Limited
478,627UK£34.7k249%no data
0.6%
Raymond James Wealth Management Limited
430,206UK£31.2k57.4%no data
0.6%
BNP Paribas SA
429,950UK£31.2k206%no data
0.57%
Investec Group
406,000UK£29.4k0%no data
0.54%
Puma Investment Management Limited
387,797UK£28.1k1,660%0.03%
0.54%
IG Group Holdings plc
381,425UK£27.7k0%no data
0.48%
University of Leeds
339,800UK£24.6k0%3.39%
0.41%
KBC Group NV
292,789UK£21.2k-1.12%0.01%
0.39%
Fidelity International Ltd
276,186UK£20.0k5.93%no data
0.3%
Evelyn Partners Investment Management LLP
215,100UK£15.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/07 01:46
End of Day Share Price 2025/10/22 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tissue Regenix Group plc is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher DonnellanCavendish
Nyeok LeeJefferies LLC
Paul CuddonPeel Hunt LLP